Skip to main content
. Author manuscript; available in PMC: 2023 Dec 17.
Published in final edited form as: J Am Board Fam Med. 2019 Sep-Oct;32(5):739–745. doi: 10.3122/jabfm.2019.05.190026

Table 2:

Bivariate Comparison Between Controlled and Uncontrolled D5 Patients

Uncontrolled Controlled p-value
N (%) 3378 (51.3%) 3210 (48.7%) NA

Age, yrs mean (SD) 58.4 (12.6) 61.7 (11.8) <0.001

Gender, Female (%) 1521 (45.0%) 1409 (43.9%) 0.359

Race, Non-white (%) 468 (13.9%) 419 (13.1%) 0.348

Language, Non-english (%) 235 (7.0%) 190 (5.9%) 0.088

Education <0.001
Unknown
712 (21.1%)

524 (16.3%)
Some High School
77 (2.3%)

75 (2.3%)
High School or GED
792 (23.4%)

734 (22.9%)
Some College or 2yr degree
1042 (30.8%)

901 (28.1%)
College Graduate
430 (12.7%)

497 (15.5%)
Post-Graduate Studies
325 (9.6%)

479 (14.9%)

Charlson comorbidity, mean (SD) 1.5 (1.2) 1.5 (1.2) 0.266

Initial Hemoglobin a1c, mean (SD) 8.0 (1.8) 7.2 (1.4) <0.001

Endocrine Consult (%) 805 (23.8%) 661 (20.6%) 0.002

Total # Visits, mean (SD) 21.4 (21.8) 21.5 (21.6) 0.168

Continuity Measures
Entropy, mean, median, (SD) 3.59, 3.59 (0.69) 3.55, 3.56 (0.69) 0.034
UPC, mean (SD) 0.34, 0.29 (0.20) 0.34, 0.29 (0.19) 0.333
COC, mean (SD) 0.14, 0.08 (0.18) 0.15, 0.09 (0.18) 0.008
SECON, mean (SD) 0.19, 0.13 (0.21) 0.18, 0.13 (0.20) 0.848